FDA Inspection 1084698 — Rhode Island Blood Center, a Division of New York Blood Center, Inc., Westerly Donor Center

Rhode Island Blood Center, a Division of New York Blood Center, Inc., Westerly Donor Center — FEI 3010167719

The FDA completed an inspection of Rhode Island Blood Center, a Division of New York Blood Center, Inc., Westerly Donor Center on March 8, 2019 in Westerly, RI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 8, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Westerly, RI (United States)